Keros Therapeutics (KROS) Other Non-Current Assets (2019 - 2026)
Keros Therapeutics' Other Non-Current Assets was $1.45 million in Q2 2026, unchanged from $1.45 million a year earlier.
Powered by 
Analysis
Keros Therapeutics (KROS) Other Non-Current Assets (2019 - 2026) Analysis & Trends
From Q1 2019 onward, Keros Therapeutics has reported Other Non-Current Assets for 29 quarters.
- Other Non-Current Assets shows a five-year compound annual growth rate of 66.0% (FY2020 to FY2025).
- In earlier years, Other Non-Current Assets was $2.06 million in FY2024 (+0.2%), $2.05 million in FY2023 (+54.6%), $1.33 million in FY2022 (unchanged) and $1.33 million in FY2021.
- Quarterly Other Non-Current Assets has moved between $1.21 million (Q3 2023) and $2.06 million (Q4 2024) over five years.
- Compared with a year earlier, Other Non-Current Assets was higher in four of the last seven quarters, with growth averaging 4.2%.
- The best year-over-year quarter for Other Non-Current Assets over five years was Q4 2023 (growth of 54.6%); the worst was Q4 2025 (a decline of 29.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 7.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 14.27 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 10.73 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 19.60 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 12.98 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 4.75 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 9.94 Bn |
| 10 | Keros Therapeutics | 221.17 Mn | -1.71 Bn | - | 1.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.45 Mn |
| Dec 31, 2025 | 1.45 Mn |
| Sep 30, 2025 | 1.45 Mn |
| Jun 30, 2025 | 1.45 Mn |
| Mar 31, 2025 | 3.36 Mn |
| Dec 31, 2024 | 4.95 Mn |
| Sep 30, 2024 | 1.45 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 1.21 Mn |
| Dec 31, 2023 | 4.48 Mn |
| Sep 30, 2023 | 1.21 Mn |
| Jun 30, 2023 | 1.33 Mn |
| Mar 31, 2023 | 1.33 Mn |
| Dec 31, 2022 | 1.33 Mn |
| Sep 30, 2022 | 1.33 Mn |
| Jun 30, 2022 | 1.33 Mn |
| Mar 31, 2022 | 1.33 Mn |
| Dec 31, 2021 | 1.33 Mn |
| Sep 30, 2021 | 1.33 Mn |
| Jun 30, 2021 | 115,000.00 |
API Access
Keros Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();